[Efficacy of levofloxacin 500 mg for middle ear diseases].

Takashi Kimitsuki, Takamasa Yoshida, Shizuo Komune

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)


We examined the cases that prescribed levofloxacin (LVFX) 500mg for middle ear diseases in our hospital. LVFX 500mg was prescribed in 18 cases (7 male, 11 female, 24-81 years old). LVFX was mainly used for the following clinical conditions, 1) otitis media with granulation proliferation: 3 cases, 2) infection to an artificial materials : 5 cases, 3) treatment for or prevention against the inflammation of the inner ear: 4 cases. Three of eighteen cases were ineffective by LVFX treatment. Bacteriological examination indicated LVFX-resistant MRSA or Pseudomonas aeruginosa were isolated in these three cases.

Original languageEnglish
Pages (from-to)43-48
Number of pages6
JournalFukuoka igaku zasshi = Hukuoka acta medica
Issue number2
Publication statusPublished - Feb 2012
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)


Dive into the research topics of '[Efficacy of levofloxacin 500 mg for middle ear diseases].'. Together they form a unique fingerprint.

Cite this